Boardroom Alpha
Boardroom Alpha
FMC · Current Report (Form 8-K) · Filed June 23, 2026

Fmc Corp — Current Report (Form 8-K)

Form
8-K
Filed
June 23, 2026
Period
Jun 18, 2026
Ticker
FMC
Accession
0000037785-26-000114
Boardroom Alpha · Filing insights

FMC entered a framework to sell part of its Newark, DE Stine Research Center to Ercor Elkton for about $114 million and lease back the operated facilities; proceeds to pay down debt, with a Q4 close.

About Fmc Corp
Market cap
$1.4B
1Y TSR
−70.9%
3Y TSR
−48.6%
Board grade
C-
Sector
Basic Materials
CEO
Pierre R Brondeau
Last annual meeting: Apr 28, 2026 · View full Fmc Corp profile →
fmc-20260618

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________
 FORM 8-K
_______________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 18, 2026
__________________________________________________________________________
FMC CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________ 
Delaware1-237694-0479804
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)(I.R.S. Employer
Identification No.)
2929 Walnut StreetPhiladelphiaPennsylvania19104
(Address of Principal Executive Offices)(Zip Code)

Registrant’s telephone number, including area code: 215-299-6000
__________________________________________________________________________


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.10 per shareFMCNew York Stock Exchange

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act


Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act.




ITEM 1.01    ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On June 18, 2026, FMC Corporation ("FMC") entered into a framework agreement (the "Agreement") to sell its property in Newark, Delaware to Ercor Elkton, LLC for gross cash proceeds of approximately $114 million, subject to a due diligence period and other closing conditions and adjustments. The proposed transaction involves the sale of underutilized buildings and land on the Delaware portion of FMC's campus at the Stine Research Center. The parties intend to negotiate in good faith a form of lease agreement for FMC to leaseback the facilities we actively operate from Ercor Elkton, LLC.
The transaction is structured to minimize any disruption to our research operations and our Stine Research Center will continue to operate at the site following the transaction. Core research activities and scientific infrastructure remain fully in place, and we do not expect any impact to our research and development capabilities. We will retain ownership of the adjacent Maryland property. The transaction is expected to close in the fourth quarter, subject to a due diligence period and other closing conditions and adjustments, and the proceeds are expected to be used to pay down debt. As is customary for transactions of this kind, the parties may elect to renegotiate certain terms during the diligence period and to amend the framework agreement accordingly. The Agreement also contemplates that the form of the leaseback agreement and various other operational and economic terms are still to be agreed between the parties and are therefore at a preliminary stage. As a result, there can be no assurance that the Agreement will ultimately result in any transaction.
The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:
This Current Report on Form 8-K contains statements that are “forward-looking” and provide other than historical information, including statements regarding the Agreement, the ability to negotiate a leaseback agreement, any impact on FMC's research operations, and the expected timing of and proceeds from the transaction.
In some cases, FMC has identified these forward-looking statements by such words or phrases as “outlook,” “will likely result,” “is confident that,” “expect,” “expects,” “should,” “could,” “may,” “will continue to,” “believe,” “believes,” “anticipates,” “predicts,” “forecasts,” “estimates,” “projects,” “potential,” “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10-K”), the section captioned “Forward-Looking Information” in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the SEC. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
ITEM 9.01.     FINANCIAL STATEMENTS AND EXHIBITS
(d)     Exhibits
10.1    Real Estate Purchase and Sale Agreement Between FMC Corporation and Encor Elkton, LLC




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
FMC CORPORATION
(Registrant)
By:/s/ ANDREW D. SANDIFER
Andrew D. Sandifer
Executive Vice President and Chief Financial Officer
Date: June 23, 2026


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Fmc Corp (FMC)

Reference

Frequently asked questions

When did Fmc Corp file this 8-K?
Fmc Corp (FMC) filed this Current Report (Form 8-K) with the SEC on June 23, 2026. The accession number assigned by EDGAR is 0000037785-26-000114.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
FMC entered a framework to sell part of its Newark, DE Stine Research Center to Ercor Elkton for about $114 million and lease back the operated facilities; proceeds to pay down debt, with a Q4 close. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Fmc Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Fmc Corp has filed under CIK 37785, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer